Announcements
M.-H. Schmid, A. Morell, Robin Cooper(University of Gothenburg), Marina Bagnoli(Fondazione IRCCS Istituto Nazionale dei Tumori), Patrice Morel, Giuseppe Mancuso(University of Messina), T. Tsuchida, Paula Walk(Europa-Universität Flensburg), G. Cazzolato, Philippe Saïag(Université de Versailles Saint-Quentin-en-Yvelines), Yoshihiro Nitta, Pham My‐Chan Dang(Centre National de la Recherche Scientifique), Véronique Saada(Université Paris-Saclay), Z. Sangiorgi, Iria Neri(Azienda USL di Bologna), L. Itschner, Naoki Kanda(Jichi Medical University), P. Preda, D.-W. Lee, Annalisa Patrizi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), B.-K. Cho, Karl Holubar, Merril M. Cooper, S. Cambiaghi, P. Elsner, Maria Bernier, U. Hinnen, P. Eisner, E. Bangha, S Marzaduri, Takeshi Watanabe, H. Assier‐Bonnet, Katsuyoshi Tamaki, Luca Fiorillo(Università degli Studi di Enna Kore), E. Snater, Christophe Bédane, P. Duller, G. La Regina, W. Verheek-Gijsbers, N. Delpuget-Berlin, P.C.M. van de Kerkhof(Radboud University Nijmegen), A. Gaddi(Istituto Nazionale di Fisica Nucleare, Sezione di Pisa), R. M. Berdondini, P. Bernard(Hôpital Dupuytren), Gabriele Bittolo Bon, H.C. Korting(Ludwig-Maximilians-Universität München), Gen Sobue(Nagoya University), J.-M. Bonnetblanc, T. Clérici, Joonho Shim(Samsung Medical Center)
Cited by 0
Related Papers
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
|The Lancet Oncology|2017|780
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
|European Journal of Cancer|2016|579
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations
|Cancer Discovery|2017|457
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
|Journal of Clinical Oncology|2015|419
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment
|European Journal of Cancer|2020|324